Protocols: Cell Medica strikes a TCR research deal with University College London; UK offers early access to AbbVie's venetoclax
A few months after striking a CAR-T pact with Baylor, Cell Medica has struck a deal to work with University College London on new …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
